Emerging Legal and Compliance issues with Artificial Intelligence in Lifesciences
Join us for our next Legal Answers Workshop (LAW) series on “Emerging Legal and Compliance issues with Artificial Intelligence in Life Sciences.” In this session, Ballard Spahr attorneys will be joined by FDA regulatory specialists to delve into the complex landscape of AI and life sciences. This program will discuss:
- FDA regulation of AI in medical devices
- AI in drug discovery and development
- Cybersecurity Issues
- Intellectual Property Issues and Risks
Moderator: Ryan Udell, Partner and Life Sciences Industry Team Co-Leader, Ballard Spahr
Speakers:
- Charley Brown, Partner and Artificial Intelligence Team Leader, Ballard Spahr
- Gail Javitt, Director, Hyman, Phelps and McNamara, P.C.
CLE Credits:
This program is approved for 1.0 in CA, NY, & PA; and 1.2 NJ. Uniform Certificates of Attendance will also be provided for the purpose of seeking credit in other jurisdictions. Any questions regarding the CLE Credits, please contact Donna Calvin, Professional Development Specialist for CLE, Ballard Spahr, at [email protected].
Agenda:
9:00am - 10:00am: Welcome & Discussion
10:00am - 10:30am: Breakout Sessions
Refunds and Questions:
- Refund/cancellation policy: This program is offered free of charge to LSPA Members in good standing. As such refunds are not applicable.
- Questions about Membership: If you are not sure you are a member or whether your membership dues are up-to-date, please contact Lois Stephens, Membership Director, [email protected]
- Questions about the Event: Contact Natalie George - [email protected]
Ballard Spahr LLP is an AmLaw 100 law firm with more than 600 attorneys in 15 US offices. We provide results-driven counsel and exceptional service in more than 50 practice areas. We are a destination practice for life sciences businesses, serving them from innovation to commercialization. Our life sciences lawyers—many of whom hold advanced degrees in the sciences—understand the complex, industry-specific issues at play. Our dedicated team includes lawyers who focus on corporate, litigation, IP and real estate matters specific to the life sciences industry.
